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The amino acid sequence of bovine brain micro glutamic acid-rich protein was determined by analysis of 
tryptic and Trimeresurus jlavoviridis protease peptides of the molecule. The protein comprised 82 amino 
acid residues and has an M, of 8992. The established sequence was highly homologous (90% identity) to 
the sequence of C-terminal 82 residues of the neurofilament 68-kDa protein from porcine spinal cord; there 
are differences of 8 residues which could be species-specific amino acid substitutions. This indicates that 
the micro glutamic acid-rich protein may arise by a restricted proteolysis of the neurotilament 68-kDa pro- 
tein, with the break occuring toward the C-terminus. 
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1. INTRODUCTION 
Micro glutamic acid-rich protein (MGP) is an 
acidic (pZ = 3.9) low molecular mass (IO-kDa) pro- 
tein found in bovine brain tissue [l]. This protein 
has a characteristic amino acid composition. There 
are only S-10 amino acid types, with no 
‘hydrophobic’ amino acids, and glutamic 
acid/glutamine accounts for 50% of the total com- 
position. Nomata et al. [2] isolated the human 
equivalent of this protein and demonstrated im- 
munochemically that it is distributed in brain 
tissue. However, no biological activities have been 
found for this protein so far. 
Recently Geisler et al. [3] have presented the par- 
tial amino acid sequence of one of the three 
neurofilament triplet proteins, often referred to as 
the 68-kDa protein. They defined two structurally 
distinct domains. The N-terminal domain shares a 
number of structural characteristics in common 
with non-neuronal intermediate filament proteins, 
Abbreviations: MGP, micro glutamic acid-rich protein; 
HPLC, high performance liquid chromatography 
while the C-terminal domain has a structure which 
is rather specific to neurofilament protein. It has 
been postulated that the N-terminal domain allows 
the 68-kDa protein to polymerize into the filament 
structure and the C-terminal domain provides a 
scaffold for interaction with other cellular com- 
ponents [3]. Weber and Geisler [4] also noticed 
that the structure of the C-terminal domain 
resembled MGP in terms of amino acid composi- 
tion and N-terminal sequence. 
We report here the amino acid sequence of MGP 
isolated from bovine brain cytosolic fraction. The 
sequence suggests that MGP arise by a restricted 
proteolysis of the neurofilament 68-kDa protein, 
where the cleavage takes place at a Lys-Asp bond 
in the C-terminal domain. 
2. MATERIALS AND METHODS 
MGP was purified from bovine brain extract as 
described in [l]. The final purification was 
achieved by preparative HPLC performed on a 
column (18 x 200 mm) of Hitachi gel 3013 resin 
(Hitachi, Tokyo) using an acetonitrile-trifluoro- 
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acetic acid solvent system [5]. Digestions of MGP 
(OS-1 mg) with L-(1-tosylamido-2-phenyl)ethyl 
chloromethyl ketone-treated trypsin (Millipore, 
NJ) or with a neutral protease from Trimeresu~s 
flavoviridis were carried out in 50 mM ammonium 
bicarbonate (pH 8.1) for 0.5-5 h at an enzyme- 
substrate ratio of 1 :50 (w/w). The digests were 
subsequently applied to a column (4.6 x 250 mm) 
of Finepak-sil ODS (Japan Spectroscopic, Tokyo) 
or of Develosil ODS (Nomura Chemicals, Aichi) 
and peptides eluted by a mobile phase gradient of 
acetonitrile in 0.1% (v/v) trifluoroacetic acid. Se- 
quence analyses including amino acid analysis, car- 
boxypeptidase digestion, hydrazinolysis, and Ed- 
man degradation followed by HPLC identification 
of the resulting phenylthiohydantoin amino acids 
were performed as in [6,7] with modifications to 
adapt for micro-scale experiments [8,9]. 
3. RESULTS AND DISCUSSION 
The amino acid sequence of MGP was deduced 
from tryptic and Trimeresurus protease peptides of 
the molecule. Fig.1 shows the sequence of MGP 
and the peptides used to establish the sequence. 
The tryptic peptides were obtained from two 
batches of digests which differed in the extent of 
cleavage. By a 30-min digestion, the tryptic 
cleavage of the MGP molecule occurred preferen- 
tially at Lys-60 and Lys-79 and generated 3 
fragments, T I-60, T 61-79, and T 80-82. Fur- 
ther extended digestion (5 h) produced an addi- 
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Fig.2. Separation of the tryptic peptides of MGP by 
reversed phase HPLC. The tryptic peptides obtained 
after 5 h digestion of MGP (100 nmol) were applied to 
a column (4.6 x 250 mm) of Develosil ODS (3 pm) and 
eluted as described in section 2. 
tional 7 peptides, T 1-14, T 15-39, etc. (fig.2), 
while T 80-82 and a portion (30%) of T 61-79 re- 
mained uncleaved. Sequential Edman degradation 
of these tryptic peptides followed by quantitative 
examination of the resulting phenylthiohydantoin 
amino acids by HPLC, and carboxypeptidase 
digestions supplementarily used for the C-terminal 
analysis enabled determination of most of the 
MGP sequence shown in fig.1. The sequence of 
residues 33-37 was hardly evaluated from the 
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Fig. 1. The amino acid sequence of bovine brain MGP and peptides needed for the sequence determination. T refers 
to tryptic peptides and TF to T. fI~vov~r~d~s protease peptides. 
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analyses of T 15-39 and T 15-46 due to a low 
yield of corresponding phenylthiohydantoin amino 
acids. Therefore it was determined by the analysis 
of a Trimeresurus protease peptide TF 3 l-37. The 
total sequence of MGP was established from the 
sequence of these peptides and the sequence of 3 
overlapping peptides TF 38-58, TF 59-77, and 
TF 78-82 (fig.l), which was derived from the 
Trimeresurus protease digest of MGP. The 
established sequence (fig.1) accounted for the 
reported amino acid composition recalculated 
from [l]; Asp 3.6 (4), Thr 1.7 (2), Ser 0.9 (l), 
Glu + Gln 42.0 (41), Pro 2.5 (2), Gly 7.0 (7), Ala 
15.8 (15), and Lys 9.5 (lo), where numbers in 
parentheses are the numbers of residues computed 
from the sequence. Based on the sequence, MGP 
is composed of 82 residues and has an Mr of 8992. 
This value is in close agreement with that estimated 
by gel electrophoresis analysis [l]. 
Earlier, we presented the sequence of N-terminal 
18 residues [l]. This sequence, based on Edman 
degradation of an intact MGP, differs from the 
final sequence by the assignment of residues 14 and 
16; we have previously located glutamic acid at 
both these positions instead of lysines in fig.1. 
Here, using proteolytic fragments, these residues 
have easily been identified because residue 14 
locates at the C-terminus of T 1-14 (it was a site 
of tryptic cleavage) and residue 16 locates next to 
the N-terminus of T 15-39 and T 15-46. The 
results were clear and conclusive. Reinspection of 
the previous Edman degradation data has also 
revealed that there were increases in lysine residues 
at steps 14 and 16. We have therefore concluded 
that lysines are at these positions. It is likely that 
the highly repetitive sequence of glutamic acid at 
positions 9-13 caused an unexpected degree of 
carry-over toward the subsequent Edman degrada- 
tion steps [l] and led us to an erroneous interpreta- 
tion of the data for these steps. 
Weber and Geisler [4] noticed that the amino 
acid composition and N-terminal sequence of 
MGP resembled that of the C-terminal region of 
the neurofilament 68-kDa protein, and suggested 
the relationship between these proteins. A com- 
parison of the established MGP sequence and the 
equivalent sequence of the 68-kDa protein 
demonstrates, in fact, a striking degree of 
homology between the sequence; there are dif- 
ferences of only 8, among 82, amino acid residues 
(fig.3). Considering that these differences could be 
amino acid substitutions due to divergence of the 
two species, it is likely that MGP arises by a 
restricted proteolytic cleavage of the neurofilament 
68-kDa protein as suggested by Weber and Geisler 
[4]. We note that all the observed differences are 
compatible to single nucleotide-base mutations in 
their triplet codons. 
The proteolytic processing of neurofilaments 
has been observed in previous reports [lo] and is 
now considered to be a normal intracellular event 
somehow related to cytoplasmic transport in 
neurons [11,12]. It occurs in the presence of 
calcium [lo] and there is some evidence that 
calcium-activated protease is responsible for this 
process [ 13,141. However, details of the cleavage 
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Fig.3. Comparison of the established sequence of bovine brain MGP with the sequence of the C-terminal 106 residues 
of the neurofilament 6%kDa protein (NF) from porcine spinal cord [3]. The difference lies in 8 positions (boxed). The 
vertical arrow indicates the cleavage site. The amino acid residues are numbered beginning with the N-terminus of MGP 
and the preceding residues are designated by negative numbers. 
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mechanism and specificity, or of the resulting mor- 
phological changes in neurofiiament are unknown. 
In order to generate the MGP molecule, the 
cleavage of the 58-kDa protein should have oc- 
curred at a Lys(- I)-Asp(l) bond (fig.3). The se- 
quence of MGP suggests that this specificity is con- 
siderably high because 10 iysine residues, including 
the cleavage sequence Lys-Asp, still occur in the 
MGP sequence (fig.1). Although it has so far re- 
mained unclear whether this cleavage takes place in 
vivo or during the MGP preparation we note that 
the procedure for purifying MGP includes EDTA, 
an inhibitor of putative calcium activated protease, 
at a relatively high concentration (I mM), in this 
procedure we have constantly obtained MCP from 
the brain cytosolic fraction at a level of 1 mglkg 
wet tissue [l]. 
Based on the structural comparison among in- 
termediate filament proteins, Geisier et al. [3] 
postulated that the C-terminal domain of the 
68-kDa protein, including the MGP sequence, 
determines ‘neurofitament specificity’ by pro- 
viding a highly charged scaffold suitable for in- 
teraction with other cellular components. From 
this viewpoint, the proteoiytie removal of MGP 
may be a regulatory mechanism of neurofil~ment 
architecture as it should result in an altered interac- 
tion and cause morphological changes in 
neurofiiaments. Alternatively, it is possible that 
the free MGP molecule plays a unique biological 
role in vivo. 
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